IS7558A - Blanda af NMDA mótlyfi og asetýlkólín esterasa hindrum fyrir meðhöndlun á Alzheimers-sjúkdómnum - Google Patents

Blanda af NMDA mótlyfi og asetýlkólín esterasa hindrum fyrir meðhöndlun á Alzheimers-sjúkdómnum

Info

Publication number
IS7558A
IS7558A IS7558A IS7558A IS7558A IS 7558 A IS7558 A IS 7558A IS 7558 A IS7558 A IS 7558A IS 7558 A IS7558 A IS 7558A IS 7558 A IS7558 A IS 7558A
Authority
IS
Iceland
Prior art keywords
alzheimer
disease
mixture
treatment
acetylcholine esterase
Prior art date
Application number
IS7558A
Other languages
English (en)
Icelandic (is)
Inventor
Lykke Thomsen Lars
Gersel Pedersen Anders
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28051666&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS7558(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/DK2003/000342 external-priority patent/WO2003101458A1/en
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of IS7558A publication Critical patent/IS7558A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS7558A 2002-05-31 2004-11-26 Blanda af NMDA mótlyfi og asetýlkólín esterasa hindrum fyrir meðhöndlun á Alzheimers-sjúkdómnum IS7558A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200200844 2002-05-31
PCT/DK2003/000342 WO2003101458A1 (en) 2002-05-31 2003-05-22 A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease

Publications (1)

Publication Number Publication Date
IS7558A true IS7558A (is) 2004-11-26

Family

ID=28051666

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7558A IS7558A (is) 2002-05-31 2004-11-26 Blanda af NMDA mótlyfi og asetýlkólín esterasa hindrum fyrir meðhöndlun á Alzheimers-sjúkdómnum

Country Status (9)

Country Link
KR (1) KR101016927B1 (ko)
CN (1) CN1655793A (ko)
AR (1) AR040121A1 (ko)
CA (1) CA2426492C (ko)
EA (1) EA007632B1 (ko)
IS (1) IS7558A (ko)
PE (1) PE20040623A1 (ko)
UA (1) UA82480C2 (ko)
ZA (1) ZA200409147B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA107653U (uk) 2012-10-01 2016-06-24 Общєство С Огранічєнной Отвєтствєнностью "Валєнта-Інтєллєкт" Композиція лікарських засобів для лікування та профілактики поведінкових, психічних та когнітивних розладів
CN118290279A (zh) * 2014-05-29 2024-07-05 广州喜鹊医药有限公司 具有神经保护作用的金刚烷胺硝酸酯化合物的盐
WO2018062941A1 (ko) * 2016-09-30 2018-04-05 주식회사 바이오파마티스 도네페질 또는 그의 약학적으로 허용 가능한 염 및 메만틴 또는 그의 약학적으로 허용 가능한 염을 함유하는 치매 및 인지기능 장애 예방 또는 치료용 약학 조성물 및 이의 제조방법
KR20210072569A (ko) 2019-12-09 2021-06-17 주식회사 종근당 도네페질 및 메만틴을 포함하는 복합 제제

Also Published As

Publication number Publication date
CN1655793A (zh) 2005-08-17
UA82480C2 (uk) 2008-04-25
KR20050024296A (ko) 2005-03-10
CA2426492A1 (en) 2003-09-16
CA2426492C (en) 2006-10-03
EA200401617A1 (ru) 2005-06-30
PE20040623A1 (es) 2004-09-11
KR101016927B1 (ko) 2011-02-28
ZA200409147B (en) 2006-06-28
EA007632B1 (ru) 2006-12-29
AR040121A1 (es) 2005-03-16

Similar Documents

Publication Publication Date Title
IS2457B (is) Samsetningar af lyfjum (t.d. klórprómasíni og pentamídíni) fyrir meðhöndlun á æxlistruflunum
NO20045434L (no) En kombinasjon av en NMDA-antagonist og acetylkolinesteraseinhibitorer for behandlingen av Alzheimers sykdom
ATE350375T1 (de) 17beta-hydroxysteroid dehydrogenase type 3 inhibitoren zur behandlung von androgen- abhängigen erkrankungen
DE60124291D1 (de) Extrusions-blasgeformter zusammendrückbarer behälter und verfahren zu dessen herstellung
ATE494279T1 (de) Zur behandlung von durch crth2 vermittelten krankheiten geeignete pyrimidinderivate
ATE361058T1 (de) Tablette und verfahren zur herstellung derselben
FR2846545B1 (fr) Implant d'osteosynthese intramedullaire
DE50310782D1 (de) Piezoaktor und verfahren zu dessen herstellung
DK1726658T3 (da) Fremgangsmåde til fremstilling af dihydroxyestere og derivater deraf
DE60218451D1 (de) 15-keto-prostaglandine zur behandlung arzneimittelinduzierter obstipation
DE60224880D1 (de) Mikrobolometer und verfahren zu dessen herstellung
IS7163A (is) Aðferðir til meðhöndlunar á lungnasjúkdómi
DE60319197D1 (de) Maraging-Stahl und Verfahren zu dessen Herstellung
ITMI20020773A0 (it) Farmaci per il trattamento dell'artrite
DE60238959D1 (de) Piezoelektrischer Oszillator und Verfahren zu dessen Herstellung
DK1420028T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
DE60100527D1 (de) Lederhänliches blattförmiges produkt und verfahren zu dessen herstellung
DK1367061T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
DE60231875D1 (de) Kartographisches bildsyntheseverfahren
IS7558A (is) Blanda af NMDA mótlyfi og asetýlkólín esterasa hindrum fyrir meðhöndlun á Alzheimers-sjúkdómnum
ATE289987T1 (de) Integriertes kohlenwasserstoffsyntheseverfahren
DE50201312D1 (de) Metall-keramik-verbundwerkstoff und verfahren zu dessen herstellung
IS2273B (is) Aðferð fyrir nýsmíðina á HIV próteasa lötum
DE50307382D1 (de) Piezoaktor und verfahren zum herstellen des piezoaktors
DK1380591T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutiske acceptable salte heraf